Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!

被引:10
|
作者
Santoro, Rita Carlotta [1 ]
Molinari, Angelo Claudio [2 ]
Leotta, Marzia [1 ]
Martini, Tiziano [3 ]
机构
[1] Azienda Osped Pugliese Ciaccio, Hemostasis & Thrombosis Unit, I-88100 Catanzaro, Italy
[2] IRCCS Ist Giannina Gaslini, Thrombosis & Hemostasis Unit, I-16147 Genoa, Italy
[3] Cesena Gen Hosp, Ctr Congenital Bleeding Disorders, Immunohaematol & Transfus Med, I-47521 Cesena, Italy
来源
MEDICINA-LITHUANIA | 2023年 / 59卷 / 06期
关键词
activated partial thromboplastin time (aPTT); coagulation factor defect; mixing test; intrinsic pathway; circulating anticoagulants; bleeding patient; LABORATORY IDENTIFICATION; CLINICAL-SIGNIFICANCE; LUPUS ANTICOAGULANT; FACTOR INHIBITORS; COAGULATION; HEMOPHILIA; MANAGEMENT; ANTIBODIES; DIAGNOSIS; HEMOLYSIS;
D O I
10.3390/medicina59061169
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activated partial thromboplastin time (aPTT) is a fundamental screening test for coagulation disturbances. An increased aPTT ratio is quite common in clinical practice. How the detection of prolonged activated aPTT with a normal prothrombin time is interpreted is therefore very important. In daily practice, the detection of this abnormality often leads to delayed surgery and emotional stress for patients and their families and may be associated with increased costs due to re-testing and coagulation factor assessment. An isolated, prolonged aPTT is seen in (a) patients with congenital or acquired deficiencies of specific coagulation factors, (b) patients receiving treatment with anticoagulants, mainly heparin, and (c) individuals/patients with circulating anticoagulants. We summarize here what may cause an isolated prolonged aPTT and evaluate the preanalytical interferences. The identification of the cause of an isolated prolonged aPTT is of the utmost importance in ensuring the correct diagnostic workup and therapeutic choices.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Diabetes Mellitus Is Associated with Shortened Activated Partial Thromboplastin Time and Increased Fibrinogen Values
    Zhao, Ying
    Zhang, Jie
    Zhang, Juanwen
    Wu, Jianping
    PLOS ONE, 2011, 6 (01):
  • [32] Influence of Preanalytical Variables on Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen
    Kim, Hyunjung
    Kim, Yonggoo
    Lee, Hae Kyung
    CLINICAL LABORATORY, 2015, 61 (09) : 1337 - 1340
  • [33] CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis
    Yang, Fanchun
    Wang, Qingying
    Ma, Rui
    Deng, Fangzhen
    Liu, Jie
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2024, 17 : 251 - 261
  • [34] C-reactive protein-induced activated partial thromboplastin time prolongation in heparinized samples is attenuated by elevated factor VIII
    Kostousov, Vadim
    Devaraj, Sridevi
    Bruzdoski, Karen
    Hensch, Lisa
    Hui, Shiu-Ki
    Teruya, Jun
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (01) : 139 - 142
  • [35] Recommendations for Appropriate Activated Partial Thromboplastin Time Reagent Selection and Utilization
    Fritsma, George A.
    Dembitzer, Francine R.
    Randhawa, Ankush
    Marques, Marisa B.
    Van Cott, Elizabeth M.
    Adcock-Funk, Dorothy
    Peerschke, Ellinor I.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (06) : 904 - 908
  • [36] Plasma Antiphospholipid Antibodies Effects on Activated Partial Thromboplastin Time Assays
    Yao, Ke
    Zhang, Lingyun
    Zhou, Hang
    Tang, Ning
    Li, Dengju
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 354 (01) : 22 - 26
  • [37] BEDSIDE MONITORING OF HEPARIN-THERAPY - COMPARISON OF ACTIVATED CLOTTING TIME TO ACTIVATED PARTIAL THROMBOPLASTIN TIME
    REINER, JS
    COYNE, KS
    LUNDERGAN, CF
    ROSS, AM
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1994, 32 (01): : 49 - 52
  • [38] Difference in activated partial thromboplastin time values with two different reagents according to C-reactive protein values
    Ishihara, Yuya
    Doi, Hiroki
    Sato, Seiko
    Ito, Hiroyasu
    LABORATORY MEDICINE, 2024, : 7 - 14
  • [39] A clot waveform analysis-based system for differential diagnosis of prolonged activated partial thromboplastin time in plasma samples
    Shimonishi, Naruto
    Ogiwara, Kenichi
    Onishi, Kengo
    Kawabe, Toshiki
    Nishio, Tomohisa
    Nogami, Keiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, 121 (02) : 151 - 160
  • [40] Use of a modified activated partial thromboplastin time to detect lupus anticoagulants
    Cloherty, T
    Golden, EA
    Lind, SE
    THROMBOSIS RESEARCH, 1996, 83 (02) : 137 - 142